|
|
||||||||
1From the Schepens Eye Research Institute and 2Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts; and the 3Bauer Center for Genomics Research, Harvard University, Cambridge, Massachusetts.
PURPOSE. To characterize the whole spectrum of gene expression changes induced by diabetes in retinal Müller glial cells.
METHODS. Müller cells were isolated from the retina of streptozotocin-diabetic and age-matched control rats by gradient centrifugation and immediately processed for RNA isolation. The gene expression profile of Müller cells was studied with the GeneChip Rat Genome oligonucleotide array (Affymetrix, Santa Clara, CA). The upregulation of acute-phase proteins in the retina of diabetic rats was confirmed by Northern and Western blot analyses. Real-time-RT-PCR was used to study the retinal expression of inflammatory cytokines.
RESULTS. Gene expression profiling identified 78 genes as differentially expressed in diabetic Müller cells. One third of these genes were associated with inflammation, including a large cluster (18% of the differentially expressed genes) of acute-phase response proteins:
2-macroglobulin, ceruloplasmin, complement components, lipocalin-2, metallothionein, serine protease inhibitor-2, transferrin, tissue inhibitor of metalloproteases-1, transthyretin, and the transcription factor C/EBP
. Northern and Western blot analyses confirmed the upregulation of
2-macroglobulin and ceruloplasmin in the diabetic retina, but not in the cerebral cortex and liver of the same animals. The acute-phase response of Müller cells in diabetes was associated with upregulation of interleukin (IL)-1ß in the retina.
CONCLUSIONS. Müller cells acquire a complex and specific reactive phenotype in diabetes characterized by the induction of acute-phase response proteins and other inflammation-related genes. The concomitant upregulation of IL-1ß in the retina of diabetic rats points to this cytokine as a possible mediator of the acute-phase response mounted by Müller cells in diabetes.
This article has been cited by other articles:
![]() |
C. B. Lupien, C. Bolduc, S. Landreville, and C. Salesse Comparison between the Gene Expression Profile of Human Muller Cells and Two Spontaneous Muller Cell Lines Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5229 - 5242. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Walker and J. J. Steinle Role of {beta}-Adrenergic Receptors in Inflammatory Marker Expression in Muller Cells Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5276 - 5281. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Carrasco, C. Hernandez, A. Miralles, P. Huguet, J. Farres, and R. Simo Lower Somatostatin Expression Is an Early Event in Diabetic Retinopathy and Is Associated With Retinal Neurodegeneration Diabetes Care, November 1, 2007; 30(11): 2902 - 2908. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. deS. Senanayake, J. Drazba, K. Shadrach, A. Milsted, E. Rungger-Brandle, K. Nishiyama, S.-I. Miura, S. Karnik, J. E. Sears, and J. G. Hollyfield Angiotensin II and Its Receptor Subtypes in the Human Retina Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3301 - 3311. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Shelton, T. S. Kern, and J. J. Mieyal Glutaredoxin Regulates Nuclear Factor {kappa}-B and Intercellular Adhesion Molecule in Muller Cells: MODEL OF DIABETIC RETINOPATHY J. Biol. Chem., April 27, 2007; 282(17): 12467 - 12474. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stasi, D. Nagel, X. Yang, L. Ren, T. Mittag, and J. Danias Ceruloplasmin Upregulation in Retina of Murine and Human Glaucomatous Eyes Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 727 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gehrig, T. Langmann, F. Horling, A. Janssen, M. Bonin, M. Walter, S. Poths, and B. H. F. Weber Genome-Wide Expression Profiling of the Retinoschisin-Deficient Retina in Early Postnatal Mouse Development Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 891 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zheng, S. J. Howell, D. A. Hatala, K. Huang, and T. S. Kern Salicylate-Based Anti-Inflammatory Drugs Inhibit the Early Lesion of Diabetic Retinopathy Diabetes, February 1, 2007; 56(2): 337 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Vincent and S. Mohr Inhibition of Caspase-1/Interleukin-1{beta} Signaling Prevents Degeneration of Retinal Capillaries in Diabetes and Galactosemia Diabetes, January 1, 2007; 56(1): 224 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Fox, X. Han, S. Kelly, A. H. Merrill Jr., R. E. Martin, R. E. Anderson, T. W. Gardner, and M. Kester Diabetes Alters Sphingolipid Metabolism in the Retina: A Potential Mechanism of Cell Death in Diabetic Retinopathy Diabetes, December 1, 2006; 55(12): 3573 - 3580. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Dunaief Iron Induced Oxidative Damage As a Potential Factor in Age-Related Macular Degeneration: The Cogan Lecture Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4660 - 4664. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Antonetti, A. J. Barber, S. K. Bronson, W. M. Freeman, T. W. Gardner, L. S. Jefferson, M. Kester, S. R. Kimball, J. K. Krady, K. F. LaNoue, et al. Diabetic Retinopathy: Seeing Beyond Glucose-Induced Microvascular Disease Diabetes, September 1, 2006; 55(9): 2401 - 2411. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vujosevic, E. Midena, E. Pilotto, P. P. Radin, L. Chiesa, and F. Cavarzeran Diabetic Macular Edema: Correlation between Microperimetry and Optical Coherence Tomography Findings. Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3044 - 3051. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Steele, D. M. Inman, D. J. Calkins, P. J. Horner, and M. L. Vetter Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 977 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Sun, C. Gerhardinger, Z. Dagher, T. Hoehn, and M. Lorenzi Aspirin at Low-Intermediate Concentrations Protects Retinal Vessels in Experimental Diabetic Retinopathy Through Non-Platelet-Mediated Effects Diabetes, December 1, 2005; 54(12): 3418 - 3426. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Sullivan, T. H. Teal, I. P. Luttrell, K. B. Tran, M. A. Peters, and H. Wessells Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats Physiol Genomics, October 17, 2005; 23(2): 192 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. St. Croix, K. Leelavaninchkul, S. C. Watkins, V. E. Kagan, and B. R. Pitt Nitric Oxide and Zinc Homeostasis in Acute Lung Injury Proceedings of the ATS, October 1, 2005; 2(3): 236 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Song, J. Wang, Y. Li, Y. Du, G. E. Arteel, J. T. Saari, Y. J. Kang, and L. Cai Cardiac Metallothionein Synthesis in Streptozotocin-Induced Diabetic Mice, and Its Protection against Diabetes-Induced Cardiac Injury Am. J. Pathol., July 1, 2005; 167(1): 17 - 26. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |